Seegene Inc
상단으로
Contact Us

Product News You can check out the latest product information

  • Launched Magicplex™ MTB Amplification

    Magicplex™ MTB Amplification1 Detection of MTB1Using READ™ technology, this product simultaneously detects both IS6110 and MPB64 genes in tuberculosis bacilli and tests for Mycobacterium tuberculosis (MTB), through Real-time PCR.Testing for IS6110 & MPB64 genes IS6110 is an insertion sequence present in the MTB genome. As most MTB have one to twenty copies of it, its presence is a useful indicator in tuberculosis tests. There have, however, been reports of MTB strains without this gene, and in such a case, the accuracy of diagnosis can be enhanced by testing simultaneously for IS6110 and MPB64, which is a conserved sequence present in single copy in the MTB genome. This product is designed to detect both genes, significantly improving sensitivity. Molecular detection of MTB Acid-fast bacilli (AFB) smears and culture tests have been conventionally used in the diagnosis of tuberculosis. Although AFB smears are simple and fast, they suffer from low sensitivity and specificity; culture tests are the most accurate among the standard methods, but take a long time, approximately 8 weeks, to produce results. On the other hand, nucleic acid amplification, which has emerged recently as a promising method with the advances in molecular diagnostic technology, detects MTB directly from the sample, and it is being used widely due to its high sensitivity and its ability to produce results quickly.

    Feb 07, 2010｜ Magicplex MTB Amplification

  • Launched Magicplex™ MTB Real-Time Detection

    Detection of MTB1Using READ™ technology, this product simultaneously detects both IS6110 and MPB64 genes in tuberculosis bacilli and tests for Mycobacterium tuberculosis (MTB), through Real-time PCR. Testing for IS6110 & MPB64 genes IS6110 is an insertion sequence present in the MTB genome. As most MTB have one to twenty copies of it, its presence is a useful indicator in tuberculosis tests. There have, however, been reports of MTB strains without this gene, and in such a case, the accuracy of diagnosis can be enhanced by testing simultaneously for IS6110 and MPB64, which is a conserved sequence present in single copy in the MTB genome. This product is designed to detect both genes, significantly improving sensitivity. Molecular detection of MTB Acid-fast bacilli (AFB) smears and culture tests have been conventionally used in the diagnosis of tuberculosis. Although AFB smears are simple and fast, they suffer from low sensitivity and specificity; culture tests are the most accurate among the standard methods, but take a long time, approximately 8 weeks, to produce results. On the other hand, nucleic acid amplification, which has emerged recently as a promising method with the advances in molecular diagnostic technology, detects MTB directly from the sample, and it is being used widely due to its high sensitivity and its ability to produce results quickly.

    Feb 07, 2010｜ Magicplex MTB Real-Time Detection

  • Launched Anyplex™ MTB/NTM Real-Time Detection

    Anyplex™ MTB/NTM Real-Time Detection Identification of MTB dissociated from NTM Anyplex™ MTB/NTM Real-time Detection is designed for identification of Mycobacterium tuberculosis (MTB) dissociated from non-tuberculosis mycobacteria (NTM) in various specimens such as sputum, aseptic fluids (pleural fluid, blood, bone marrow aspiration), bronchial washing, fresh tissue, culture specimens (solid and liquid culture), urine and stool. Although culture is a standard method to diagnose active tuberculosis, it is difficult to discriminate MTB from NTM by culture due to their similar colony morphologies. Anyplex™ MTB/NTM Real-time Detection is a DNA-based testing product which can accurately discriminate MTB from NTM. Therefore, this product enables a proper treatment of the patients by determining MTB from NTM infection.

    Jan 02, 2010｜ Anyplex™ MTB/NTM Real-time Detection

  • Obtained CE-IVD marking for Seeplex® MTB ACE Detection

    Seeplex® MTB ACE Detection Detection of M. tuberculosis (MTB) Seegene's Seeplex® MTB ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    May 19, 2008｜ Seeplex® MTB ACE Detection

  • Obtained CE-IVD marking for Seeplex® MTB Nested ACE Detection

    Detection of M. tuberculosis (MTB) in various specimens Seegene's Seeplex® MTB Nested ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    May 19, 2008｜ Seeplex® MTB Nested ACE Detection

  • Obtained CE-IVD marking for Seeplex® MTB/BCG ACE Detection

    Seeplex® MTB/BCG ACE Detection Discrimination of MTB from M. bovis BCG Seegene's Seeplex® MTB/BCG ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    May 19, 2008｜ Seeplex® MTB/BCG ACE Detection

  • Grand launching for pathogen testing products

    TB Detection (human), HBV Lami-resistant (human), TV4 Detection Kit (plant), and PT3 Detection Kit (plant). Seegene has successfully released a number of pathogen testing products based on multiplex PCR system. They employ Seegene’s innovative dual specificity oligonucleotide (DSO) technology and have dramatically improved specificity than other such products.

    Sep 21, 2006｜ Seeplex® TB Detection

12